Rafael Sanchez-Salas, MD, presented “HIFU: The European Experience” for the Grand Rounds in Urology audience in August 2020.
How to cite: Sanchez-Salas, Rafael. “HIFU: The European Experience” August 2020. Accessed Jul 2024. https://grandroundsinurology.com/hifu-the-european-experience/
HIFU: The European Experience – Summary:
Rafael Sanchez-Salas, MD, attending surgeon at L’Institut Mutualiste Montsouris in Paris, France, and member of the Focal Therapy Society, discusses high-intensity focused ultrasound treatment (HIFU) in the context of the European experience with focal therapy. He gives an overview of the 18 current registered clinical trials in Europe focused on HIFU, highlighting that the large majority involve only minor reported complications. Dr. Sanchez-Salas also looks at the intermediate outcomes, concluding that HIFU shows promise for lowering PSA. He also notes that improved procedural controls have led to some groundbreaking technological development. Overall, Dr. Sanchez-Salas argues that the European experience with HIFU includes some of the most relevant advances in the field of focal therapy.
Dr. Sanchez-Salas’s conflicts of interest include: EDAP-TMS, France; Intuitive Surgical, Sunnyvale, USA; Olympus Europa, Germany.
ABOUT THE AUTHOR
Rafael Sanchez-Salas, MD, is an Associate Professor of Urology in the Department of Surgery at McGill University in Montreal, Quebec. He is a surgeon and clinician-scientist whose primary interest is in minimally-invasive treatments in urological oncology. He is an established leader in the field of focal therapy for the treatment of localized prostate cancer. Dr. Sanchez-Salas earned his medical degree from the Universidad de los Andes in Mérida, Venezuela, and he was valedictorian of the class of 1998. He completed his basic surgical and urological training at Universidad Central de Venezuela in 2005.
He was awarded with scholarships from Confederacion Americana de Urologia and The European Association of Urology to pursue fellowship training in urological oncology and minimally-invasive urological surgery at Memorial Sloan Kettering Cancer Center in the US, Clinica Santa Maria in Chile, and L’Institut Mutualiste Montsouris in France, where, after his training, he joined the faculty in 2008. Dr. Sanchez-Salas has enjoyed a sound international career as a talented surgical proctor and cancer researcher. His current research priorities include focal therapy for prostate cancer and its impact on prostatic micro-environment and outcomes. He chaired the SIU-International Consultation on Urological Disease on image-guided therapy for Prostate and Renal Carcinomas in 2015.
